Critical Roles of TRAF2 and TRAF5 in Tumor Necrosis Factor-induced NF-κB Activation and Protection from Cell Death
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Tumor necrosis factor (TNF) receptor-associated factors (TRAFs) were identified as signal transducers for the TNF receptor superfamily. However, the exact roles of TRAF2 and TRAF5 in TNF-induced NF-kappaB activation still remain controversial. To address this issue, we generated TRAF2 and TRAF5 double knockout (DKO) mice. TNF- but not interleukin-1-induced nuclear translocation of NF-kappaB was severely impaired in murine embryonic fibroblasts (MEFs) derived from DKO mice. Moreover, DKO MEFs were more susceptible to TNF-induced cytotoxicity than TRAF2 knockout MEFs. Collectively, these results indicate that both TRAF2 and TRAF5 are involved in TNF-induced NF-kappaB activation and protection from cell death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among these, TRAF5 and BIRC3 have functionally redundant counterparts (TRAF2 and BIRC2) (Mahoney et al., 2008; Tada et al., 2001).”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Tada et al., 2001
Citations
Cites
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
Hsu, H., Shu, H.-B., Pan, M.-G., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1
Malinin, N. L., Boldin, M. P., Kovalenko, A. V., & Wallach, D. (1997) · Nature · doi:10.1038/385540a0 · Cited by 1,280
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Self-citation
Research works printed but not linked: 1
- Tracey, 1994, Annu. Rev. Immunol., 45, 491
Cited by
Items 101–200 of 306
Guo, X., Yin, H., Li, L., Chen, Y., Li, J., Doan, J., Steinmetz, R. N., & Liu, Q. (2017) · Circulation · doi:10.1161/circulationaha.116.026240 · Cited by 105
Ubiquitin-mediated regulation of TNFR1 signaling
Wertz, I. E., & Dixit, V. M. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.014 · Cited by 113
Distinct modes of TNF signaling through its two receptors in health and disease
Atretkhany, K. N., Gogoleva, V. S., Drutskaya, M. S., & Nedospasov, S. A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mr0120-510r · Cited by 100
Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis
Gupta, I., Singh, K., Varshney, N. K., & Khan, S. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00011 · Cited by 93
“TRAF2 has the RING E3 ligase activity and is known to polyubiquitinate RIP1 at K63, in coordination with a UBC13/UEV1 E2 enzyme (Yeh et al., 1997; Tada et al., 2001; Shi and Kehrl, 2003; Lee et al., 2004).”
BackgroundSasazuki, T., Sawada, T., Sakon, S., Kitamura, T., Kishi, T., Okazaki, T., Katano, M., Tanaka, M., Watanabe, M., Yagita, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203190200 · Cited by 86
Self-citationYOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-κB
Schimmack, G., Schorpp, K., Kutzner, K., Gehring, T., Brenke, J. K., Hadian, K., & Krappmann, D. (2017) · eLife · doi:10.7554/elife.22416 · Cited by 84
“Since we did not observe an interaction between YOD1 and TRAF2, which is involved in TNFR signaling (Hsu et al., 1996; Tada et al., 2001), we directly compared the effect of YOD1 knock-down on NF-kB activation in response to either IL-1b or TNFa stimulation (Figure 6F).”
BackgroundWu, L., Nakano, H., & Wu, Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505903200 · Cited by 90
Self-citationMcLean, L. A., Gathmann, I., Capdeville, R., Polymeropoulos, M. H., & Dressman, M. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0784-3 · Cited by 80
“Genes from our genomic profile that fit this category include CBL (47), JAK1 (43, 44), MYLK (48, 49), PAK1 (50), PIK3R1/R3 (41, 42), PPP2R2A (51), RAD9 (52), REL (53, 54), TNFSF14 (55), and TRAF5 (56, 57).”
AIMP2 promotes TNFα-dependent apoptosis via ubiquitin-mediated degradation of TRAF2
Choi, J. W., Kim, D. G., Park, M., Um, J. Y., Han, J. M., Park, S. G., Choi, E., & Kim, S. (2009) · Journal of Cell Science · doi:10.1242/jcs.049767 · Cited by 76
“Although AIMP2 could potentially function at various points in the pathway, we focused on TNF-receptor- associated factor 2 (TRAF2) as a potential target protein of AIMP2 because it plays a pivotal role in the apoptotic response to TNFα (Lee et al., 1997; Tada et al., 2001; Xia and Chen, 2005).”
BackgroundXia, Z.-P., & Chen, Z. J. (2005) · Science's STKE · doi:10.1126/stke.2722005pe7 · Cited by 77
Physiological Roles and Mechanisms of Signaling by TRAF2 and TRAF5
Au, P. Y. B., & Yeh, W. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_3 · Cited by 89
Self-citationLymphotoxin β Receptor Induces Interleukin 8 Gene Expression via NF-κB and AP-1 Activation
Chang, Y., Hsieh, S.-L. E., Chen, M.-C., & Lin, W. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5573 · Cited by 83
Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation
Tao, T., Cheng, C., Ji, Y., Xu, G., Zhang, J., Zhang, L., & Shen, A. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-09-0805 · Cited by 80
“In conclusion, these data suggest that TRAF5 is a downstream target of Numbl in suppressing glioma cell migration and invasion in a ubiquitination-dependent manner.”
BackgroundOkazaki, T., Ebihara, S., Asada, M., Yamanda, S., Niu, K., & Arai, H. (2008) · Neoplasia · doi:10.1593/neo.08140 · Cited by 73
“The assays were performed as previously shown [ 27 ].”
MethodSelf-citationSignaling crosstalk between NF-κB and JNK
Nakano, H. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.05.007 · Cited by 85
Self-citationEtemadi, N., Holien, J. K., Chau, D., Dewson, G., Murphy, J. M., Alexander, W. S., Parker, M. W., Silke, J., & Nachbur, U. (2013) · The FEBS Journal · doi:10.1111/febs.12419 · Cited by 72
TRAIL and NFκB Signaling—a Complex Relationship
Wajant, H. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)67007-5 · Cited by 84
Martínez‐Forero, I., Azpilikueta, A., Bolaños, E., Nistal‐Villán, E., Palazón, A., Teijeira, Á., Pérez-Chacón, G., Morales‐Kastresana, A., Murillo, O., Jure‐Kunkel, M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203010 · Cited by 75
Generation and Analysis of Siah2 Mutant Mice
Frew, I. J., Hammond, V. E., Dickins, R. A., Quinn, J. M. W., Walkley, C. R., Sims, N. A., Schnall, R., Della, N. G., Holloway, A. J., Digby, M. R., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9150-9161.2003 · Cited by 73
“To assess TRAF-mediated lymphocyte proliferation in Siah2 / mice, splenocytes were activated in vitro with LPS, which requires TRAF6 for induction of B-cell proliferation (30), or with CD40L, which requires TRAF2, TRAF5, and TRAF6 for optimal B-cell proliferative responses (30, 34, 35).”
BackgroundTNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling
Wicovsky, A., Salzmann, S., Roos, C., Ehrenschwender, M., Rosenthal, T., Siegmund, D., Henkler, F., Gohlke, F., Kneitz, C., & Wajant, H. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.80 · Cited by 73
Oukka, M., Kim, S. T., Lugo‐Villarino, G., Sun, J., Wu, L., & Glimcher, L. H. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00434-8 · Cited by 75
TRAF5 Functions in Both RANKL- and TNFα-Induced Osteoclastogenesis
Kanazawa, K., Azuma, Y., Nakano, H., & Kudo, A. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.3.443 · Cited by 70
“A recent publication reported that TNF induced nuclear translocation of NF- B was weakly detected in murine embryonic fibroblasts derived from TRAF2 and TRAF5 double knockout mice.((34)) These reports support our speculation in that there is an indirect relationship between TRAF6 and TNF signaling.”
BackgroundSelf-citationLymphotoxin‐β receptor mediates NEMO‐independent NF‐κB activation
Saitoh, T., Nakano, H., Yamamoto, N., & Yamaoka, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03622-0 · Cited by 68
Self-citationAshida, H., Nakano, H., & Sasakawa, C. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003409 · Cited by 77
Self-citationA Novel Caspase-2 Complex Containing TRAF2 and RIP1
Lamkanfi, M., D'Hondt, K., Walle, L. V., van Gurp, M., Denecker, G., Demeulemeester, J., Kalai, M., Declercq, W., Saelens, X., & Vandenabeele, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411180200 · Cited by 68
Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination events
Verhelst, K., Carpentier, I., & Beyaert, R. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.11.002 · Cited by 72
“and probably also TRAF5, which play essential roles in TNFinduced NF-kB signaling [44–47] (Fig.”
BackgroundThe Ubiquitin System in Immune Regulation
Park, Y., Jin, H., Aki, D., Lee, J., & Liu, Y. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00002-9 · Cited by 77
“Furthermore, TRAF2 and TRAF5 have a functional redundancy on NF-κB activation (Lee et al., 1997; Tada et al., 2001; Yeh et al., 1997).”
Jarvis, M. A., Borton, J. A., Keech, A. M., Wong, J. W., Britt, W. J., Magun, B. E., & Nelson, J. A. (2006) · Journal of Virology · doi:10.1128/jvi.00060-06 · Cited by 68
“Primary Abs used were as follows: rabbit anti-IE2 (R638; 1:300), rabbit anti-p65 NF-B (C-20; 1:300), mouse anti-gB ( 27-156 ) (1:150) (27), and mouse anti-IL-8 (clone 6217; 1:100) (R&D Systems, Inc.).”
BackgroundEsparza, E. M., Lindsten, T., Stockhausen, J. M., & Arch, R. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512915200 · Cited by 64
Chiu, Y.-H., Zhao, M., & Chen, Z. J. (2009) · Chemical Reviews · doi:10.1021/cr800554j · Cited by 62
Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer
Choi, J. W., Lee, J., Kim, J. K., Jeon, H.-K., Choi, J., Kim, D. G., Kim, B., Nam, D., Kim, H. J., Yun, S. H., et al. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs018 · Cited by 65
“Working mechanism of AIMP2-DX2 in TNF-a signaling AIMP2-F induces the TNF-induced cell death through the downregulation of TNF receptor-associated factor 2 (TRAF2) that plays a pivotal role in the TNF-a signaling pathway (Lee et al., 1997; Tada et al., 2001; Xiao, 2004; Xia and Chen, 2005).”
BackgroundGhorbaninezhad, F., Leone, P., Alemohammad, H., Najafzadeh, B., Nourbakhsh, N. S., Prete, M., Malerba, E., Saeedi, H., Tabrizi, N. J., Racanelli, V., et al. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5098 · Cited by 74
Unfolded Protein Response after Neurotrauma
Larner, S. F., Hayes, R. L., & Wang, K. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.807 · Cited by 64
“To complicate things, the protein complex IRE1 (cid:2) / TRAF2 is also involved in a pro-survival pathway which is dependent on protein synthesis mediated by activation of NF-(cid:4) B via TRAF2’s interaction with NF-(cid:4) B–inducing kinase (NIK) (Bradley and Pober, 2001; Tada et al., 2001).”
Ubiquitin: tool and target for intracellular NF-κB inhibitors
Wullaert, A., Heyninck, K., Janssens, S., & Beyaert, R. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.09.003 · Cited by 76
Eliopoulos, A. G., Davies, C. C., Blake, S. M. S., Murray, P. G., Najafipour, S., Tsichlis, P. N., & Young, L. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4567-4579.2002 · Cited by 61
“Thus, although neither TRAF2 nor TRAF5 appears to be uniquely responsible for TNF-induced NF-B activation, which occurs normally in TRAF2 or TRAF5 knockout mouse embryo fibroblasts, cells lacking both proteins are severely impaired in TNF-induced NF-B activation ( 49 ).”
BackgroundMissiou, A., Rudolf, P., Stachon, P., Wolf, D., Varo, N., Aichele, P., Colberg, C., Hoppe, N., Ernst, S., Münkel, C., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.219295 · Cited by 59
Self-citationCellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1
Hatzivassiliou, E., & Mosialos, G. (2002) · Frontiers in bioscience · doi:10.2741/hatziva · Cited by 59
Esparza, E. M., & Arch, R. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7875 · Cited by 60
“Genetic analyses argue that TRAF2 promotes signaling events triggered by TNFR-related proteins, such as NF- B activation (22, 23, 47).”
BackgroundDED or alive: assembly and regulation of the death effector domain complexes
Riley, J. S., Malik, A., Holohan, C., & Longley, D. B. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.213 · Cited by 65
The Many Roles of Ubiquitin in NF-κB Signaling
Courtois, G., & Fauvarque, M. (2018) · Biomedicines · doi:10.3390/biomedicines6020043 · Cited by 68
Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling
Broek, R. V., Snow, G. E., Chen, Z., & Waes, C. V. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.10.005 · Cited by 61
“pathway activation [30,31].”
Ju, E., Park, K. A., Shen, H., & Hur, G. M. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00847-4 · Cited by 62
Zhang, L., Blackwell, K., Shi, Z., & Habelhah, H. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.008 · Cited by 62
TNF Receptor-Associated Factor 5 Limits the Induction of Th2 Immune Responses
So, T., Salek‐Ardakani, S., Nakano, H., Ware, C. F., & Croft, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4292 · Cited by 56
Self-citationUbiquitination and TRAF signaling
Pineda, G., Ea, C.-K., & Chen, Z. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_7 · Cited by 63
TRAF2 Plays a Key, Nonredundant Role in LIGHT-Lymphotoxin β Receptor Signaling
Kim, Y., Nedospasov, S. A., & Liu, Z.-G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2130-2137.2005 · Cited by 53
“Cell culture. WT, RIP/, TRAF2/, and TRAF5/ MEF cells were previously described (28, 50 , 55).”
BackgroundMethodGururaja, T. L., Yung, S. L., Ding, R., Huang, J., Zhou, X., McLaughlin, J. R., Daniel-Issakani, S., Singh, R., COOPER, R. D. G., Payan, D. G., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.08.012 · Cited by 51
TRAF1 and Its Biological Functions
Lee, S. Y., & Choi, Y. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_2 · Cited by 51
Choi, J., Devkota, S., Sung, Y. H., & Lee, H. (2013) · Oncotarget · doi:10.18632/oncotarget.1434 · Cited by 52
“Since TNFα-induced NF-κB signaling in mice is impaired only when Traf2 and Traf5 are deficient [26], it is plausible that the simultaneous downregulation of TRAF2 and TRAF5 by EI24 results in activation of the NF-κB pathway.”
BackgroundTherapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis
Tseng, J., Chang, Y.-C., Huang, C., Hsu, L.-C., & Chuang, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071064 · Cited by 55
Nagashima, H., Okuyama, Y., Asao, A., Kawabe, T., Yamaki, S., Nakano, H., Croft, M., Ishii, N., & So, T. (2014) · Nature Immunology · doi:10.1038/ni.2863 · Cited by 49
Self-citationRNA sensor LGP2 inhibits TRAF ubiquitin ligase to negatively regulate innate immune signaling
Parisien, J.-P., Lenoir, J. J., Mandhana, R., Rodriguez, K. R., Qian, K., Bruns, A. M., & Horvath, C. M. (2018) · EMBO Reports · doi:10.15252/embr.201745176 · Cited by 52
TNF receptor signalling in autoinflammatory diseases
Jarosz-Griffiths, H., Holbrook, J. A., Reyna, S. J. L., & McDermott, M. (2019) · International Immunology · doi:10.1093/intimm/dxz024 · Cited by 50
Blackwell, K., Zhang, L., Thomas, G. S., Sun, S., Nakano, H., & Habelhah, H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00699-08 · Cited by 51
Self-citationE3 ubiquitin ligase Mule ubiquitinates Miz1 and is required for TNFα-induced JNK activation
Yang, Y., Do, H., Tian, X., Zhang, C., Liu, X., Dada, L. A., Sznajder, J. I., & Liu, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913690107 · Cited by 49
Doyle, M. S., Collins, E. S., FitzGerald, O., & Pennington, S. R. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4071 · Cited by 49
“None theless, it is important to note that within TNF signal ing the TRAF2/5 proteins have been associated with the release/activation of NF-κB [55].”
BackgroundAdada, M. M., Gandy, K. A. O., Snider, A. J., Canals, D., Hannun, Y. A., Obeid, L. M., & Clarke, C. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.489443 · Cited by 47
“Consistent with this, NF- B activation remains intact in TRAF2 knock-out mice because of TRAF5 compensation, whereas only double knock-out mice for TRAF2 and TRAF5 have defective NF- B activation (58).”
BackgroundSilke, J., & Vince, J. E. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_507 · Cited by 52
Li, S., Wang, D., Zhao, J., Weathington, N. M., Shang, D., & Zhao, Y. (2017) · The FASEB Journal · doi:10.1096/fj.201700415rr · Cited by 46
SIGNALING ACTIVATED BY THE DEATH RECEPTORS OF THE TNFR FAMILY
Anděra, L. (2009) · Biomedical Papers · doi:10.5507/bp.2009.029 · Cited by 55
Targeting TRAFs for Therapeutic Intervention
Zapata, J. M., Lefebvre, S., & Reed, J. C. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_15 · Cited by 46
Blackwell, K., Zhang, L., Workman, L. M., Ting, A. T., Iwaï, K., & Habelhah, H. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01416-12 · Cited by 49
Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO
Wang, Y., Cui, L., Yang, G., Zhan, J., Guo, L., Chen, Y. Z., Fan, C., Liu, D., & Guo, D. (2018) · Journal of Virology · doi:10.1128/jvi.00667-18 · Cited by 44
“This phenomenon suggests that TRAF2/5, but not TRAF6, are critical in TNF- mediated NF- B activation (45, 46).”
BackgroundYang, S.-K., Wang, Y., Chao, C., Chuang, Y., Lan, C., & Chen, B.-S. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-19 · Cited by 42
“TRAF5 has been implicated in the TNF-induced NF-κB activation, as in contrast to the single TRAF2 or TRAF5 knockout cells, TRAF2/TRAF5 double-knockout cells show impaired NF-κB activation upon TNF stimulation [35].”
BackgroundResultGenetic dissection of antigen receptor induced-NF-?B activation
Li, Z., Rickert, R. C., & Karin, M. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.012 · Cited by 42
Salazar, K. A., Joffe, N. R., Dinguirard, N., Houde, P., & Castillo, M. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119949 · Cited by 44
“TRAF5 protein mediates the signal transduction of NF-κβ pathway via TNF receptor activation [59, 60].”
BackgroundUpregulation of miR-29b-3p protects cardiomyocytes from hypoxia-induced apoptosis by targeting TRAF5
Cai, Y., & Li, Y. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0151-3 · Cited by 40
A systems biology approach to suppress TNF-induced proinflammatory gene expressions
Hayashi, K., Piras, V., Tabata, S., Tomita, M., & Selvarajoo, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-84 · Cited by 49
Roberts, M. L., Drosopoulos, K. G., Vasileiou, I., Stricker, M., Taoufik, E., Maercker, C., Guialis, A., Alexis, Μ. N., & Pintzas, A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21386 · Cited by 40
Xiang, Q., Chen, L., Fang, J., Hou, S., Lin, W., Bai, L., Liu, Y., Zhou, Y. N., Kijlstra, A., & Yang, P. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4293 · Cited by 37
“Overexpression can lead to inflammation and autoimmune disease, and it has also been shown to protect cells from apoptosis [26,40,43-46].”
Shibata, Y., Tokunaga, F., Goto, E., Komatsu, G., Gohda, J., Saeki, Y., Tanaka, K., Takahashi, H., Sawasaki, T., Inoue, S., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006162 · Cited by 42
Self-citationTNF-receptor-associated factors as targets for drug development
Zapata, J. M. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.3.411 · Cited by 37
CIKS/DDX3X Interaction Controls the Stability of the Zc3h12a mRNA Induced by IL-17
Somma, D., Mastrovito, P., Grieco, M., Lavorgna, A., Pignalosa, A., Formisano, L., Salzano, A. M., Scaloni, A., Pacifico, F., Siebenlist, U., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401589 · Cited by 36
Zhang, L., Blackwell, K., Thomas, G. S., Sun, S., Yeh, W., & Habelhah, H. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.054 · Cited by 37
Self-citationIyer, A. K. V., Azad, N., Talbott, S. J., Stehlik, C., Lu, B., Wang, L., & Rojanasakul, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002915 · Cited by 40
Emerging Complexity of Protein Ubiquitination in the NF- B Pathway
Habelhah, H. (2010) · Genes & Cancer · doi:10.1177/1947601910382900 · Cited by 46
Gupta, I., Varshney, N. K., & Khan, S. M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00336 · Cited by 36
Piao, J., Hasegawa, M., Heissig, B., Hattori, K., Takeda, K., Iwakura, Y., Okumura, K., Inohara, N., & Nakano, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.221853 · Cited by 40
Self-citationGenomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer
White, K. L., Rider, D. N., Kalli, K. R., Knutson, K. L., Jarvik, G. P., & Goode, E. L. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9745-4 · Cited by 40
“2 for TNFα [88, 96–103] and TCR ligand signaling pathways [18, 104–114], Fig.”
Bonif, M., Meuwis, M., Close, P., Benoît, V., Heyninck, K., Chapelle, J.-P., Bours, V., Merville, M., Piette, J. G., Beyaert, R., et al. (2006) · Biochemical Journal · doi:10.1042/bj20051659 · Cited by 39
Leonardi, A., Vito, P., Mauro, C., Pacifico, F., Ulianich, L., Consiglio, E., Formisano, S., & Jeso, B. D. (2002) · Endocrinology · doi:10.1210/endo.143.6.8825 · Cited by 35
“supported by the lack of NF- B activation after TNF stimulation in MEF derived from mice lacking both TRAF2 and TRAF5 (28).”
BackgroundLiu, J., Yan, J. R., Jiang, S., Wen, J., Chen, L., Zhao, Y., & Lin, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105176108 · Cited by 38
“It is possible that other De-repressionRecruitment Death Inflammation Activation JNK Miz1 TNF-R1 TNFα TR A D D TR A D D TR A F2 R IP 1 IKK Ub Ubc13 Ub Ub Ub Ub Ub Ub Ub Mule ?”
BackgroundInfluentialChang, E., Ha, J., Kang, S.-S., Lee, Z. H., & Kim, H. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.07.010 · Cited by 34
Murine Cytomegalovirus Virion-Associated Protein M45 Mediates Rapid NF-κB Activation after Infection
Krause, E., de Graaf, M., Fliss, P. M., Dölken, L., & Brune, W. (2014) · Journal of Virology · doi:10.1128/jvi.00684-14 · Cited by 35
Gissler, M. C., Stachon, P., Wolf, D., & Marchini, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.826630 · Cited by 41
“While it has been proposed that TRAF5 can be partially compensated by TRAF2 (158), a deficiency of TRAF5 in bone-marrow derived cells did not affect atherosclerosis in LDLR mice (103), rendering effects on lipid deposition and lower numbers of Treg cells in plaques as indirect effects.”
BackgroundTRAF6 deficiency promotes TNF-induced cell death through inactivation of GSK3β
Yoon, K., Jung, E. J., Lee, S. R., Kim, J., Choi, Y., & Lee, S.-A. (2008) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402304 · Cited by 33
Inhibitor of Apoptosis Proteins as Novel Targets in Inflammatory Processes
Mayer, B. A., Rehberg, M., Erhardt, A., Wolf, A., Reichel, C. A., Kracht, M., Krombach, F., Tiegs, G., Zahler, S., Vollmar, A. M., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.234294 · Cited by 34
New developments on the TNFα-mediated signalling pathways
Sethu, S., & Melendez, A. J. (2010) · Bioscience Reports · doi:10.1042/bsr20100040 · Cited by 38
TNAP, a Novel Repressor of NF-κB-inducing Kinase, Suppresses NF-κB Activation
Hu, W.-H., Mo, X.-M., Walters, W. M., Brambilla, R., & Bethea, J. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405699200 · Cited by 39
Bagchi, A. K., Malik, A., Akolkar, G., Jassal, D. S., & Singal, P. K. (2021) · Antioxidants · doi:10.3390/antiox10121897 · Cited by 33
“Nevertheless, NF-κB is one of the important pathways activated by TRAF2 and TRAF5 [37] leading to ER stress [38].”
BackgroundWorkman, L. M., & Habelhah, H. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.04.005 · Cited by 36
Bian, Z., Dai, J., Nakano, H., Guan, H., Yuan, Y., Gan, L., Zhou, H., Zong, J., Zhang, Y., Li, F., et al. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24669 · Cited by 31
“They argued that these results suggested a redundant role for TRAF5 in TNF‐induced NF‐kB activation, and somemolecule other than TRAF5 may mediate NF‐kB activation [Tada et al., 2001].”
BackgroundSelf-citationNorris, P. S., & Ware, C. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_13 · Cited by 36
WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-κB activation pathway
Gao, D., Wang, R., Li, B., Yang, Y., Zhai, Z., & Chen, D. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0059-6 · Cited by 32
“On the other hand, TRAF2 and TRAF5 are required for signaling by members of the TNF-receptor family [ 33 ].”
BackgroundLiu, J., Zhao, Y., Eilers, M., & Lin, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906328106 · Cited by 33
Thomas, G. S., Zhang, L., Blackwell, K., & Habelhah, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4867 · Cited by 32
Huan, W., Wu, X., Zhang, S., Zhao, Y., Xu, H., Wang, N., Li, H., Chen, H., Wei, H., & Wang, Y. (2012) · Journal of Molecular Histology · doi:10.1007/s10735-012-9411-5 · Cited by 30
Pro-apoptotic functions of TRAF2 in p53-mediated apoptosis induced by cisplatin
Tsuchida, M., Yokosawa, T., Noguchi, T., Shimada, T., Yamada, M., Sekiguchi, Y., Hirata, Y., & Matsuzawa, A. (2020) · The Journal of Toxicological Sciences · doi:10.2131/jts.45.219 · Cited by 27
“TRAF2 mediates cisplatin-induced apoptosis through the JNK activation In TNFR signaling, TRAF2 regulates the NF-κB and JNK signaling pathways in collaboration with TRAF5 and MAPK/ERK kinase kinase-1 (MEKK1), respectively (Baud et al., 1999; Yuasa et al., 1998; Tada et al., 2001).”
Sasazuki, T., Okazaki, T., Tada, K., Komazawa‐Sakon, S., Katano, M., Tanaka, M., Yagita∥, H., Okumura, K., Tominaga, N., Hayashizaki, Y., et al. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.030 · Cited by 31
Self-citationPrause, M. C. B., Berchtold, L. A., Urizar, A. I., Trauelsen, M., Billestrup, N., Mandrup-Poulsen, T. R., & Størling, J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.021 · Cited by 27
“A similar scenario is known for TNFa activation of NFkB and JNK, where redundancy between TRAF2 and TRAF5 has been demonstrated (Tada et al., 2001).”
Background
Metadata
- Authors
- Tada, K., Okazaki, T., Sakon, S., Kobarai, T., Kurosawa, K., Yamaoka, S., Hashimoto, H., Mak, T. W., Yagita, H., Okumura, K., Yeh, W.-C., & Nakano, H.
- Affiliations
- Juntendo University (JP)
- Japan Science and Technology Agency (JP)
- Tokyo Medical and Dental University (JP)
- University of Toronto (CA)
- Corresponding author
- Nakano, Hiroyasu
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 276
- Issue
- 39
- Pages
- 36530-36534
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2129668511
- Cited by
- 306
- References
- 44
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 3 · 2022: 7 · 2021: 9 · 2020: 4 · 2019: 11 · 2018: 7 · 2017: 10 · 2016: 9 · 2015: 13 · 2014: 10 · 2013: 19 · 2012: 11
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6964 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- TRAF2, TRAF5, TNF-α, NF-κB activation, TNF receptor-associated factors, TNF receptor signaling, double knockout mice, murine embryonic fibroblasts, TNF-induced cytotoxicity, cell death protection, interleukin-1
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Enzyme Activation, Fibroblasts, Humans, Interleukin-1, Plasmids, Precipitin Tests, Protein Binding, Proteins, Recombinant Proteins, Tumor Necrosis Factor-alpha, Blotting, Western, Signal Transduction, NF-kappa B, Cell Death, Mice, Knockout, TNF Receptor-Associated Factor 2, TNF Receptor-Associated Factor 5, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.